Search results for: Keyword: life sciences
Corona research: Consortium of Berlin research and industry seeks active... The Berlin biotech company Molox GmbH and a team at HZB have initiated a consortium of regional research groups and BASF. They want to identify a starting point for the development of a potential active substance against the new coronavirus.
Coronavirus SARS-CoV2: BESSY II data accelerate drug development At the Berlin X-ray source BESSY II, researchers have decoded a protein involved in the replication of the corona virus. Analysing the 3D architecture allows the systematic development of drugs which inhibit the reproduction of the virus.
20 percent more patients were treated with proton therapy in 2019 For more than 20 years, Charité - Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have jointly offered the irradiation of eye tumors with protons. In 2019, more patients were treated in Berlin-Wannsee than ever before. 276 patients - 20 ...
X-ray microscopy at BESSY II reveals how antimalaria-drugs might work An international team has now been able to investigate malaria pathogens in red blood cells under natural conditions using X-ray microscopy at BESSY II, ALBA and ESRF. They show which mechanisms are used by active substances to attack the pathogens.
Oldest completely preserved lily discovered Already 115 million years ago, tropical flowering plants were apparently very diverse and showed all typical characteristics. This is the conclusion of an international team of researchers led by Clément Coiffard, Museum für Naturkunde Berlin. The team ...